1. Home
  2. SGMT vs MPAA Comparison

SGMT vs MPAA Comparison

Compare SGMT & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • MPAA
  • Stock Information
  • Founded
  • SGMT 2006
  • MPAA 1968
  • Country
  • SGMT United States
  • MPAA United States
  • Employees
  • SGMT N/A
  • MPAA N/A
  • Industry
  • SGMT
  • MPAA Auto Parts:O.E.M.
  • Sector
  • SGMT
  • MPAA Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • MPAA Nasdaq
  • Market Cap
  • SGMT 165.4M
  • MPAA 154.5M
  • IPO Year
  • SGMT 2023
  • MPAA 1994
  • Fundamental
  • Price
  • SGMT $4.12
  • MPAA $10.44
  • Analyst Decision
  • SGMT Strong Buy
  • MPAA
  • Analyst Count
  • SGMT 7
  • MPAA 0
  • Target Price
  • SGMT $25.71
  • MPAA N/A
  • AVG Volume (30 Days)
  • SGMT 864.8K
  • MPAA 151.0K
  • Earning Date
  • SGMT 03-24-2025
  • MPAA 02-10-2025
  • Dividend Yield
  • SGMT N/A
  • MPAA N/A
  • EPS Growth
  • SGMT N/A
  • MPAA N/A
  • EPS
  • SGMT N/A
  • MPAA N/A
  • Revenue
  • SGMT N/A
  • MPAA $753,727,000.00
  • Revenue This Year
  • SGMT N/A
  • MPAA $7.30
  • Revenue Next Year
  • SGMT N/A
  • MPAA $5.96
  • P/E Ratio
  • SGMT N/A
  • MPAA N/A
  • Revenue Growth
  • SGMT N/A
  • MPAA 4.26
  • 52 Week Low
  • SGMT $2.39
  • MPAA $4.36
  • 52 Week High
  • SGMT $7.64
  • MPAA $11.50
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 43.11
  • MPAA 72.04
  • Support Level
  • SGMT $3.96
  • MPAA $5.38
  • Resistance Level
  • SGMT $4.83
  • MPAA $11.50
  • Average True Range (ATR)
  • SGMT 0.38
  • MPAA 0.87
  • MACD
  • SGMT -0.04
  • MPAA 0.47
  • Stochastic Oscillator
  • SGMT 13.39
  • MPAA 82.68

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard parts in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

Share on Social Networks: